ANRO · Alto Neuroscience, Inc.
Market Cap
$1.40B
Shares
39.24M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-27 | 2026-08-26 | |
| 8-K | 2026-08-12 | — | |
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-07-14 | 2026-07-13 | |
| 8-K | 2026-07-13 | — | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-28 | 2026-05-27 | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-13 | 2026-05-12 | |
| 8-K | 2026-04-01 | — | |
| DEF 14A | 2026-03-26 | 2026-05-12 | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-20 | 2025-10-19 | |
| 8-K | 2025-08-13 | 2025-08-12 | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-07-08 | 2025-07-03 | |
| 8-K | 2025-06-26 | — | |
| 8-K | 2025-06-03 | 2025-05-31 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | 2025-05-13 | |
| DEF 14A | 2025-04-01 | 2025-05-13 | |
| 8-K | 2025-03-20 | 2025-03-17 | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-02-12 | — | |
| 8-K | 2025-02-03 | — | |
| 8-K | 2025-01-16 | 2025-01-13 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-10-22 | — | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-07-29 | 2024-07-24 | |
| 8-K | 2024-05-21 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-14 | — | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-03-11 | 2024-03-08 | |
| 8-K | 2024-02-06 | — |
Showing 1–44 of 44 filings
Key facts
CIK
1999480
CUSIP
02157Q109
13F (30d)
90 filings
90 filers
Visit website
Investor relations